Membership2
Representing our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.
Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.
We work with members in England, Scotland, Wales and Northern Ireland.
Latest news
Online Workshop on SMC: How to prepare and submit to SMC | 11-12 March 2024
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Latest economic data underlines risk of disincentivising UK life sciences growth
The government has published the latest economic data for UK’s life sciences sector for the year 2021/22 showing strong growth in both jobs and sector turnover across the years of the Covid-19 pandemic.
Government sends mixed message to global life science investors
The government has published new terms for the Statutory Scheme for branded medicines, maintaining sales rebates at levels which have damaged the UK’s international standing with global life science companies.
ABPI response to UK Biobank whole genome sequencing dataset
The UK Biobank has revealed a new data from whole genome sequencing from half a million participants.
We are the only full-service trade association supporting members throughout the life-cycle of a branded medicines, from early discovery to patients.
We provide a wide range of services and support for our members. ABPI provides its members with a comprehensive monitoring package and regular updates.
In total, we have over 150 members: our Full Members represent many established research based pharmaceutical companies, our Research Affiliate Members are involved primarily in pharmaceutical research and development, whilst our General Affiliate members are organisations that work with the pharmaceutical industry in the UK.
We work for our members in two ways
Developing a compelling single voice for the prescription medicines and research & development industries
With stakeholders in the life-sciences and healthcare arena, to spread our messages to Government and other stakeholders for the benefit of patients
Working on behalf of member companies of all sizes
There is an opportunity for our member companies to be engaged with a wide range of industry activities.
Our Smaller Companies Board Sponsored Group is dedicated to supporting and addressing the specific issues and needs impacting this particular defined group of companies.
Two members of the Smaller Companies Board Sponsored Group also sit on the ABPI Board in order that this sector of industry is also reflected in wider ABPI considerations and approaches.
Adding value to our members
We offer additional value to our members through a range of proactive services in the form of up to date information and briefings, as well as a wide range of Industry data and resources to draw upon and utilise. The aim of this is to keep our members and their employees in touch with the latest issues and dynamics of the pharmaceutical industry in the UK.
Our expert teams can be drawn upon by all our members as required, to support and discuss your particular challenges, in addition to a wide range of information through our extranet to which all members are given access upon joining the ABPI.
There are many benefits of becoming a member of the ABPI and we are always happy to visit companies and discuss these in greater detail. If you would like to arrange a company visit, please contact the Membership Services – 0207 747 1414.